insights_auto
为什么 8NE 上涨了 2.44%?
深入探索chevron_right
8NE:FRA
Lisata Therapeutics, Inc.
€0.84
arrow_upward
+2.44%(+0.020) 1 天
10月14日, GMT+2 08:05:06 · EUR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 8NE 生成关键数据洞见…
开盘价
€0.84
最高价
€0.84
最低价
€0.84
市值
1166.84万
平均成交量
0.00
成交量
0.00
52 周最高价
€4.34
52 周最低价
€0.74
员工人数
21
开盘价
€0.84
最高价
€0.84
最低价
€0.84
市值
1166.84万
平均成交量
0.00
成交量
0.00
52 周最高价
€4.34
52 周最低价
€0.74
员工人数
21
新闻报道
来自网络来源和新闻合作伙伴
CoinDesk
·
2小时前
标普500期权成为该超流动交易所最热门的押注
Traders Union
·
9小时前
Ryan Detrick：遵循中期选举年后的市场规律，S&P 500 自 2026 年 3 月 30 日以来上涨约 18%
FOREX.com
·
1天前
油价与美元齐涨 道琼斯指数逆势三连阳
资料
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Lisata Therapeutics, Inc.简介